October 02, 2024

Lupus Nephritis: Key Urinary Biomarkers

A recent study has identified urinary proteins as significant predictors of specific renal lesions in lupus nephritis, offering valuable insights into pathogenic signal pathways. Source: Arthritis & Rheumatology

Conexiant

October 02, 2024

Teen Prediabetes: A Hidden Risk for Pregnancy Complications

New study finds preconception prediabetes in teens and young adults more than doubles gestational diabetes risk, suggesting a critical window for early intervention and screening.

Conexiant

September 30, 2024

Lupus Treatment Trial Paused Following Patient Deaths

Three of the fatalities showed a common pattern of symptoms and the deaths happened close to the time of dosing, while a non-fatal adverse event showed a similar proximity to dosing.

Reuters

September 27, 2024

Over 3,600 Food Contact Chemicals Found in Humans

Eighty FCCs had properties that warrant further investigation for potential health concerns, such as carcinogenic, mutagenic, and reproductive toxicity.

Conexiant

September 26, 2024

Iron Deficiency Widespread in U.S. Adult Population

Iron deficiency affects nearly 1 in 7 U.S. adults, with functional deficiency surpassing absolute deficiency in all groups except women under 50.

Conexiant

September 19, 2024

Study: Each 1% HbA1c Drop Cuts CKD Risk 4% in T2D

A retrospective study of over 13,000 T2D patients found that each 1% BMI reduction independently lowered cardiovascular disease risk by 4% in those treated with GLP-1RAs.

Conexiant

September 19, 2024

iValve May Reduce Anticoagulation Need in Preliminary In Vitro Study

A recent study introduced the iValve, a novel mechanical heart valve, which may reduce the need for lifelong anticoagulation therapy while maintaining durability and enhancing hemodynamic performance.

Conexiant

September 19, 2024

Steroid Use Doubled Diabetes Risk in UK Study

UK study of 451,606 hospitalized patients reveals systemic glucocorticoid use associated with 2.6-fold increased risk of new-onset diabetes, with incidence rates of 51.9 vs 18.5 per 100 person-years in exposed vs unexposed groups.

Conexiant

September 18, 2024

Mycophenolate Mofetil Reduces Severe Flares in New-Onset SLE

A recent trial in China found that adding mycophenolate mofetil to standard therapy for patients with new-onset systemic lupus erythematosus reduced severe flare-ups and lupus nephritis.

Conexiant